Authors :
Dr. Sunkara Surya Lakshmi; Dr. K. Atchuta Kumar; K. Bhargav; D. Sai Shamitha; D. Vineeth Ram
Volume/Issue :
Volume 8 - 2023, Issue 11 - November
Google Scholar :
https://tinyurl.com/ycy77r6d
Scribd :
https://tinyurl.com/39z8y2fk
DOI :
https://doi.org/10.5281/zenodo.10282992
Abstract :
The metabolic disease known as juvenile
diabetes, or Type 1 diabetes is characterized by a
reduction in insulin production, which is vital for an
individual’s survival. Islet-cell-transplantation is an
experimental approach of transferring pancreatic islet
cells from donor pancreas to a suitable diabetic patient.
Upon implantation the islets begin to produce insulin that
is sufficient to maintain blood glucose levels. In this
review we discuss what is currently known about
pancreatic islet transplantation, its risks and benefits.
Based on current evidence, pancreatic islet
transplantation appears to be an experimental surgery
that is demonstrating promising outcomes for the
patients. However, islet transplantation have not been
studied comprehensively enough to introduce it as a
routine procedure.
The metabolic disease known as juvenile
diabetes, or Type 1 diabetes is characterized by a
reduction in insulin production, which is vital for an
individual’s survival. Islet-cell-transplantation is an
experimental approach of transferring pancreatic islet
cells from donor pancreas to a suitable diabetic patient.
Upon implantation the islets begin to produce insulin that
is sufficient to maintain blood glucose levels. In this
review we discuss what is currently known about
pancreatic islet transplantation, its risks and benefits.
Based on current evidence, pancreatic islet
transplantation appears to be an experimental surgery
that is demonstrating promising outcomes for the
patients. However, islet transplantation have not been
studied comprehensively enough to introduce it as a
routine procedure.
